On Demand Webinar

Flow Cytometry can interrogate multiparametric measurements on individual cells and has become a widely used specialty testing platform for clinical trials. In addition to the importance of evaluating single-cell analysis throughout the drug development lifecycle, there are increasingly new flow cytometry instruments being introduced that can enhance the researcher’s ability to produce high-quality patient results.

One of the challenges that exist when conducting a global clinical trial is the ability to standardize laboratory flow cytometers across sites while also producing rigorous and comparable results in either an exploratory or critical endpoint analysis.

Key Topics:

• Important considerations when designing and validating cytometry panels for use across multiple sites and instruments.
  
  
• Understanding aspects of flow cytometry assessments in either a regulatory or non-regulatory setting.
  
  
• Validation of a high-complexity Immuno-Oncology panel to interrogate human patient samples as part of a global clinical trial.
  
  

Meet Our Presenter:

Federica De Paoli, PhD, Senior Flow Scientist, Champions Oncology